Nanobusiness News

RSS

Alnylam Submits CTA for Lipid Nanoparticle-Based RNAi TTR, ALN-TTR02

Alnylam Pharmaceuticals, a company specializing in RNAi therapeutics, has announced the submission of a clinical trial application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to start a Phase I clinical study of its RNAi therapeutic targeting transthyretin (TTR) called ALN-TTR02 for treating TTR-mediated amyloidosis (ATTR).

10 Jan 2012

Nanocrystalline Cellulose Presentation by CelluForce at BioPlastek 2012 Forum

CelluForce, a Canada-based joint venture between Domtar and FPInnovations, will deliver a presentation about its novel nano-crystalline cellulose material and its performance-enhancing capabilities at the forthcoming BioPlastek 2012 Forum.

9 Jan 2012

MonoSol Rx and Nanomedicine Firm Midatech Form Joint Venture Company

Midatech, a nanomedicine company developing MidaForm nanoparticle excipients, and MonoSol Rx, a company developing PharmFilm drug delivery technology, have formed a joint venture company, MidaSol Therapeutics.

9 Jan 2012

Tetragenetics Reports Preclinical Study Results of Nanoparticle-Based Influenza Vaccine

Tetragenetics, a developer of recombinant vaccines, has presented preclinical study findings of an influenza vaccine candidate based on nanoparticles.

7 Jan 2012

Checkpoint Technologies Releases 3.0 NA SIL for Laser Scanning Microscopy System

Checkpoint Technologies, a provider of laser scanning and photon emission microscopy systems for applications in the failure analysis industry, has unveiled its 3.0 numerical aperture (NA) solid immersion lens objective (SIL).

7 Jan 2012

STATS ChipPAC Breaks Ground for New Plant to Bolster Advanced Wafer Level Technologies

STATS ChipPAC, a provider of semiconductor advanced packaging and test solutions, has conducted the groundbreaking ceremony for its new plant to be built close to its existing facility in Yishun, Singapore, to expand its production capabilities for sophisticated wafer level technologies such as through silicon via (TSV), integrated passive devices (IPD), wafer level chip scale packaging (WLCSP) and embedded wafer level ball grid array (eWLB).

7 Jan 2012

Alnylam Reports Positive Results for Nanotech-Enabled RNAi Therapeutic Targeting PCSK9

Tekmira Pharmaceuticals, a company specializing in novel RNA interference (RNAi) therapeutics, has announced that Alnylam Pharmaceuticals has reported encouraging initial results from its continuing human clinical study of a target-specific RNAi therapeutic for PCSK9 called ALN-PCS for treatment of dangerous hypercholesterolemia using the lipid nanoparticle technology of Tekmira.

7 Jan 2012

Major Chip Provider Places Orders for ANTARES Single-Wafer CryoKinetic Systems

FSI International, a provider of surface conditioning technology, devices and support services for the production of microelectronics, has declared that it has received orders from a major equipment manufacturer for several ANTARES cryokinetic cleaning systems.

7 Jan 2012

Nanometrics to Deliver Presentation at Conference in New York

Nanometrics, a provider of sophisticated process control solutions and systems has declared that its CEO and president, Dr Timothy Stultz will deliver an address at the 14th Annual Needham Growth Conference.

5 Jan 2012

Strategic Partnership to Develop Silicon Magnetics Using Enpirion’s MEMS Magnetics Technology

Enpirion and JiangyinChangdian Advanced Packaging (JCAP) have signed a strategic collaboration deal to produce silicon-based magnetics using the micro-electronic magnetic silicon (MEMS) technology of Enpirion.

5 Jan 2012